• EP1 is one of four identified EP receptors, EP1, EP2, EP3, and EP4 which bind with and mediate cellular responses principally to prostaglandin E2) (PGE2) and also but generally with lesser affinity and responsiveness to certain other prostanoids (see Prostaglandin receptors). (wikipedia.org)
  • The following standard prostaglandins have the following relative potencies in binding to and activating EP1: PGE2≥PGE1>PGF2alpha>PGD2. (wikipedia.org)
  • The receptor binding affinity Dissociation constant Kd (i.e. ligand concentration needed to bind with 50% of available EP1 receptors) is ~20 nM and that of PGE1 ~40 for the mouse receptor and ~25 nM for PGE2 with the human receptor. (wikipedia.org)
  • Because PGE2 activates multiple prostanoid receptors and has a short half-life in vivo due to its rapidly metabolism in cells by omega oxidation and beta oxidation], metabolically resistant EP1-selective activators are useful for the study of EP1's function and could be clinically useful for the treatment of certain diseases. (wikipedia.org)
  • This compound has a Ki inhibitory binding value (see Biochemistry#Receptor/ligand binding affinity) of 150 nM compared to that of 25 nM for PGE2 and is therefore ~5 times weaker than PGE2. (wikipedia.org)
  • When initially bound to PGE2 or other stimulating ligand, EP1 mobilizes G proteins containing the Gq alpha subunit (Gαq/11)-G beta-gamma complex. (wikipedia.org)
  • Prostaglandin E2 (PGE2) is a predominant proinflammatory regulator that plays pivotal roles in regulating tumor cell proliferation, migration, and invasion. (uthsc.edu)
  • However, the PGE2 receptor subtype (EP1-EP4) which potentially contributed to NB growth remained elusive. (uthsc.edu)
  • In this research, at first, we demonstrated that EP2 receptor was highly correlated with NB aggressiveness, and acted as a predominant Gαs-coupled receptor mediating PGE2-initiated cyclic AMP (cAMP) signaling in NB cells with high-risk factors, including chromosome 11q deletion and MYCN amplification. (uthsc.edu)
  • Prostaglandin E2 (PGE2) is widely produced in different organs from different species, with relevance in several gastrointesti- nal (GI) functions [1] including mucosal protection, secretion and motility [2]. (fxr-agonists.com)
  • PGE2 targets four G-protein coupled EP receptors: EP1 , EP2 , EP3 and EP4. (fxr-agonists.com)
  • One of the difficulties to identify the receptor involved in PGE2 response has been the lack of selective antagonists to discriminate between EP receptor sub- types. (fxr-agonists.com)
  • Another study has shown that PGE2 contracts longitudinal smooth mus- cle in human colon through EP1 receptors and both mouse ileum and colon through EP1 and EP3 receptors, whereas activation of EP2 receptor by butaprost reduces the tension in the three preparations [17]. (fxr-agonists.com)
  • IL-1β induces cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2). (biomedcentral.com)
  • Activation of EP1 receptors induces cal- cium mobilization and they are considered "contractile" receptors. (fxr-agonists.com)
  • These results indicate that inhibition of GPR39-1b induces Sucrase a decrease in anxiety-related behaviors and disturbs appetite. (nartsignaling.com)
  • Prostaglandin E1 induces vasodilation and inhibits platelet aggregation. (medchemexpress.com)
  • The aim of the study was to identify the receptor involved in prostaglandin E 2 (PGE 2 )-induced relaxation in guinea pig, murine, monkey, rat and human airways in vitro . (bmj.com)
  • Carbacylin, 17-phenyltrinor PGE1, and several other tested compounds are dual EP1/EP3 antagonists (most marketed prostanoid receptor antagonists exhibit poor receptor selectivity). (wikipedia.org)
  • Since, this rise in cytosolic Ca2+ can also contract muscle cells, EP1 has been classified as a contractile type of prostanoid receptor. (wikipedia.org)
  • The activation of protein kinases C feeds back to phosphorylate and thereby desensitizes the activated EP1 receptor (see homologous desensitization but may also desensitize other types of prostanoid and non-prostanoid receptors (see heterologous desensitization). (wikipedia.org)
  • Affinity at human Prostanoid EP3 receptor in the human embryonic kidney (HEK) 293 cell line. (bindingdb.org)
  • Prostaglandin E1 (Alprostadil) is a prostanoid receptor ligand, with K i s of 1.1 nM, 2.1 nM, 10 nM, 33 nM and 36 nM for mouse EP3 , EP4 , EP2 , IP and EP1 , respectively. (medchemexpress.com)
  • Pharmacological inhibition of EP2 by our recently developed antagonist TG6-129 substantially suppressed the NB tumor growth in both nude mice and syngeneic immunocompetent hosts, with the observable anti-inflammatory, anti-angiogenic, and apoptotic effects. (uthsc.edu)
  • We observed that pharmacological inhibition of 12-LOX resulted in a significant reduction in both platelet procoagulant phenotype ex vivo, and thrombocytopenia and thrombosis in our humanized mouse model of HIT in vivo. (bvsalud.org)
  • We will discuss issues related to the biochemistry and selective pharmacological inhibition of COX enzymes, and further refer to their expression in the brain under normal conditions and following excitotoxicity and ischemic cerebral injury. (southampton.ac.uk)
  • Concurrently with the mobilization of these pathways, ligand-activated EP1 stimulates ERK, p38 mitogen-activated protein kinases, and CREB pathways that lead to cellular functional responses. (wikipedia.org)
  • Protease-activated receptors (PARs) are a class of integral membrane proteins that are cleaved by a variety of proteases, most notably thrombin, to reveal a tethered ligand and promote activation. (bvsalud.org)
  • SC51322 (Ki=13.8 nM), GW-848687 (Ki=8.6 nM), ONO-8711, SC-19220, SC-51089, and several other synthetic compounds given in next cited reference are selective competitive antagonists for EP1 that have been used for studies in animal models of human diseases. (wikipedia.org)
  • Studies using animals genetically engineered to lack EP1 and supplemented by studies using treatment with EP1 receptor antagonists and agonists indicate that this receptor serves several functions. (wikipedia.org)
  • Methods Using an extensive range of pharmacological tools, the relaxant potential of PGE 2 and selective agonists for the EP 1-4 receptors in the presence and absence of selective antagonists in guinea pig, murine, monkey, rat and human isolated airways was investigated. (bmj.com)
  • Washed platelets had been pelleted by centrifugation in the current presence of prostaglandin E1 (PGE1,?1?M) and resuspended in fresh calcium-free Tyrodes (CFT). (morainetownshipdems.org)
  • CONCLUSIONS: These data demonstrate for the first time the need for dual platelet receptor (PAR and FcγRIIA) stimulation for fibrin formation in HIT in vivo. (bvsalud.org)
  • Finally EP3 receptors, termed the "inhibitory" receptors, reduce cAMP levels and lead to contraction [11]. (fxr-agonists.com)
  • Moreover, during this phase an enrichment in genes involved in the formation of the lipid droplets was evidenced as well as the activation of the thyroid-receptor/retinoic X receptor (TR/RXR) and the peroxisome proliferator activated receptors (PPARs) signalling pathways. (biomedcentral.com)
  • In contrast to previous publications, a role for the EP 4 receptor in relaxant responses in human airways in vitro was found. (bmj.com)
  • PGE analogues are usu- ally not specific for an EP receptor with the exception of butaprost, which specifically binds to EP2 receptors [1]. (fxr-agonists.com)
  • EP2 inhibition with our drug-like compounds could be potentially applied as an alternative, and adjunctive treatment strategy for this deadly pediatric cancer. (uthsc.edu)
  • 48 h) concentration-dependently reduces HUVECs proliferation (up to 100% inhibition) in the presence of VEGF (20 ng/mL), with an IC 50 of 400 nM [2] . (medchemexpress.com)
  • EP2 and EP4 receptor activation increases cAMP and causes smooth muscle relaxation. (fxr-agonists.com)
  • Results In agreement with previous studies, it was found that the EP 2 receptor mediates PGE 2 -induced relaxation of guinea pig, murine and monkey trachea and that the EP 4 receptor mediates PGE 2 -induced relaxation of the rat trachea. (bmj.com)
  • Conclusion Identification of the receptor mediating PGE 2 -induced relaxation represents a key step in developing a novel bronchodilator therapy. (bmj.com)
  • Despite that COX-2 is typically considered an inducible isoform highly expressed during the inflammatory state, a constitutive expression has been demonstrated in several GI tissues, including the murine proximal colon, where products derived from constitutive COX-2 seem to contribute to the tonic inhibition of the contractile activity of circular smooth muscle layer [6]. (fxr-agonists.com)
  • These data have been confirmed in murine airways from EP 2 receptor-deficient mice ( Ptger2 ). (bmj.com)
  • However, the expression of EP1 In humans, its expression appears to be more limited: EP1 receptors have been detected in human mast cells, pulmonary veins, keratinocytes, myometrium, and colon smooth muscle. (wikipedia.org)
  • According to their effects on smooth muscle, the four EP receptors can be classified in two groups: "relax- ant" EP2 and EP4 receptors and "contractile" EP1 and EP3 receptors [10]. (fxr-agonists.com)
  • METHODS: Using human and mouse model systems, we investigated the cooperativity of PARs (protease-activated receptors) and FcγRIIA in HIT. (bvsalud.org)
  • Studies in mice, rats, and guinea pigs have found EP1 Messenger RNA and protein to be expressed in the papillary collecting ducts of the kidney, in the kidney, lung, stomach, thalamus, and in the dorsal root ganglia neurons as well as several central nervous system sites. (wikipedia.org)
  • The PTGER1 gene is located on human chromosome 19 at position p13.12 (i.e. 19p13.12), contains 2 introns and 3 exons, and codes for a G protein-coupled receptor (GPCR) of the rhodopsin-like receptor family, Subfamily A14 (see rhodopsin-like receptors#Subfamily A14). (wikipedia.org)
  • The G protein-coupled receptor 39-b (GPR39-1b) is a splice variant of which is expressed in the central nervous and gastrointestinal systems. (nartsignaling.com)
  • High resolution crystal structure of human β 2 -adrenergic G protein-coupled receptor. (guidetoimmunopharmacology.org)
  • However, key differences in the distribution of EP1 between these test animals and humans as well as other complicating issues make it difficult to establish the function(s) of this receptor in human health and disease. (wikipedia.org)
  • Nevertheless, for a complete agonist, a decrease A1 in receptor amount is predicted to lessen the noticed potency from the agonist33, which provides previously been confirmed for CRPXL-induced aggregation in platelets with 50% degrees of GPVI34. (morainetownshipdems.org)
  • Animal model studies have implicated EP1 in various physiological and pathological responses. (wikipedia.org)
  • A number of clinical studies have reported beneficial effects of inhaled PGE 2 on airway calibre in normal subjects and patients with asthma and COPD, and we have identified a role for the EP 4 receptor in these relaxant responses. (bmj.com)
  • One feasible description for these total outcomes is certainly a decrease in surface area receptor amount, either by losing or internalisation. (morainetownshipdems.org)
  • 4) It suppresses stress-induced impulsive behavior and social dysfunction in mice by suppressing the activation of Dopamine receptor D1 and Dopamine receptor D2 signaling. (wikipedia.org)
  • These desensitizations limit further EP1 receptor activation within the cell. (wikipedia.org)
  • HIT is a life- and limb-threatening adverse drug reaction with an immune response following the formation of ultra-large immune complexes that drive platelet activation through the receptor FcγRIIA. (bvsalud.org)
  • EP receptor expression varies depending on the tissue and the cell type [1]. (fxr-agonists.com)
  • Taken jointly, these data highly support a reversible, competitive system of actions for citalopram, rather than reduction in surface area receptor expression. (morainetownshipdems.org)
  • Prostaglandin E2 receptor 1 (EP1) is a 42kDa prostaglandin receptor encoded by the PTGER1 gene. (wikipedia.org)
  • Hou, Ruida ( https://orcid.org/0000-0002-9040-8223 ), "Targeting Prostaglandin E2 Receptor EP2 for Treatment of High-Risk Neuroblastoma" (2023). (uthsc.edu)
  • These data explain the lack of bronchodilator activity observed with selective EP 2 receptor agonists in clinical studies. (bmj.com)
  • the receptor for obestatin, but current evidence does not support this hypothesis. (nartsignaling.com)
  • Only one such agonist that is highly selective in stimulating EP1 has been synthesized and identified, ONO-D1-OO4. (wikipedia.org)
  • Prostaglandin E1 can be used as a vasodilator for the research of peripheral vascular diseases. (medchemexpress.com)